Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$5.78 +0.05 (+0.87%)
At close: Oct 20, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Current Debt (2011)

Updated

Analysis

Tonix Pharmaceuticals Holding (TNXP) Current Debt (2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -5.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 64.00 Mn
10 Tonix Pharmaceuticals Holding 96.15 Mn -663.24 Mn 12.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 17,741.00
API Access

Tonix Pharmaceuticals Holding Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TNXP&period=max&api_key=YOUR_API_KEY